EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?

Asifa Khan iD, Jiaxin Ling iD, Jinlin Li

Viruses · 2024

DOI: 10.3390/v16091491 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Asifa Khan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Microbiology, The Biomedical Center, Uppsala University, P.O. Box 582, 751 23 Uppsala, Sweden. Hauptthemen laut MEDLINE: Autophagy, SARS-CoV-2, COVID-19, Antiviral Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Åke Wibergs stiftelse, Carl Tryggers Stiftelse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As obligate parasites, viruses need to hijack resources from infected cells to complete their lifecycle. The interaction between the virus and host determines the viral infection process, including viral propagation and the disease’s outcome. Understanding the interaction between the virus and host factors is a basis for unraveling the intricate biological processes in the infected cells and thereby developing more efficient and targeted antivirals. Among the various fundamental virus–host interactions, autophagy plays vital and also complicated roles by directly engaging in the viral lifecycle and functioning as an anti- and/or pro-viral factor. Autophagy thus becomes a promising target against virus infection. Since the COVID-19 pandemic, there has been an accumulation of studies aiming to investigate the roles of autophagy in SARS-CoV-2 infection by using different models and from distinct angles, providing valuable information for systematically and comprehensively dissecting the interplay between autophagy and SARS-CoV-2. In this review, we summarize the advancements in the studies of the interaction between SARS-CoV-2 and autophagy, as well as detailed molecular mechanisms. We also update the current knowledge on the pharmacological strategies used to suppress SARS-CoV-2 replication through remodeling autophagy. These extensive studies on SARS-CoV-2 and autophagy can advance our understanding of virus–autophagy interaction and provide insights into developing efficient antiviral therapeutics by regulating autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagySARS-CoV-2COVID-19Antiviral AgentsVirus ReplicationHumansCOVID-19 Drug TreatmentHost-Pathogen InteractionsAnimals

Stichwörter der Autor:innen

SARS-CoV-2antiviralsautophagyautophagy modulatorincomplete autophagyvirophagy

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Medical Biochemistry and Microbiology, The Biomedical Center, Uppsala University, P.O. Box 582, 751 23 Uppsala, Sweden.
  • Biochemistry Unit, Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
  • Zoonosis Science Center, Uppsala University, 751 23 Uppsala, Sweden.

ORCID-Profile: Asifa Khan, Jiaxin Ling

Förderung

  • Swedish Research Council
  • Åke Wibergs stiftelse
  • Carl Tryggers Stiftelse
  • Börjesson E o R stipends from Uppsala University

Zitieren

APA

Khan, A., Ling, J., & Li, J. (2024). Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?. Viruses. https://doi.org/10.3390/v16091491

Vancouver

Khan A, Ling J, Li J. Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?. Viruses. 2024. doi:10.3390/v16091491

BibTeX
@article{Khan2024,
  author = {Khan, Asifa and Ling, Jiaxin and Li, Jinlin},
  title = {Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16091491}
}
Kostenlos starten →